Base Year
Historical Year
Forecast Year
The global polymyalgia rheumatica treatment market attained a value of about USD 203.73 million in 2023. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 4.7% to reach nearly USD 308.68 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Polymyalgia is usually treated with medications such as corticosteroids to ease symptoms and uneasiness. Steroids are one of the most common drugs for polymyalgia rheumatica treatment. It can ease pain and stiffness in a few days. However, the use of the drug requires extensive monitoring as it can lead to serious side effects, such as loss of bone density, cataracts, and high blood pressure. This leads to routine diagnostic tests to monitor the effect and treatment of the disease, hence augmenting the industry growth. Moreover, the growing demand for immune suppressing medications such as methotrexate in the early course of treatment is significantly contributing to the market growth.
In addition, the development of drugs that can treat various rheumatological diseases, such as polymyalgia rheumatica and rheumatoid arthritis, is propelling the market growth. This is expected to surge its demand among people with several health-related issues, to significantly contribute to the market growth. Moreover, the introduction of clinical programs by leading companies to evaluate the safety and efficiency of novel drugs is invigorating the growth of the polymyalgia rheumatica treatment industry.
Polymyalgia rheumatica treatment is the treatment of the inflammatory disorder that causes stiffness, muscle pain, and inflammation in the hips and shoulders. It is usually prevalent among the geriatric population, especially women. It is treated by using corticosteroids, methotrexate, and vitamin D supplements.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major diagnostic methods of polymyalgia rheumatica treatment are:
The market can be broadly categorised on the basis of its drug class into:
Based on route of administration, the market is divided into:
By end use, the market is classified into:
The EMR report looks into the regional markets of polymyalgia rheumatica treatment like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing research on polymyalgia rheumatica to study its association with musculoskeletal symptoms is expected to augment the market growth. The deployment of advanced diagnostic technologies to analyse subacromial and subdeltoid bursitis of shoulders, hip synovitis, and iliopectineal bursitis, to develop their effective treatment is projected to propel the industry growth. Moreover, technological advancements in imaging tests such as magnetic resonance imaging (MRI) are minimising its scorer bias to diagnose the disease effectively. As MRI can detect asymptomatic cases of polymyalgia rheumatica, it is surging the demand for its treatment, which is consequently accelerating the market growth of polymyalgia rheumatica treatment.
As physical therapy does not result in side effects, its popularity is significantly growing. This is increasing the demand for physiotherapy in the treatment of polymyalgia rheumatica, which is propelling the industry growth. Physiotherapies are customised based on the severity of diseases to provide a personalised treatment of the disease, due to which it is increasingly being adopted. Physiotherapy can aid in enhancing cardiovascular levels, reducing stiffness, improving mobility, and increasing muscle strength to allow patients to live at norm and ease, therefore significantly contributing to the market growth. Moreover, the rising availability of specific physiotherapy programs at hospitals and speciality clinics is surging their accessibility, which is providing further impetus to the growth of the polymyalgia rheumatica treatment industry.
The report presents a detailed analysis of the following key players in the global polymyalgia rheumatica treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Diagnostic Method |
|
| Breakup by Drug Class |
|
| Breakup by Route of Administration |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
India Disposable Medical Gloves Market
Global Aortic Valve Replacement Devices Market
Global JE (Japanese Encephalitis) Vaccine Market
South Africa Orthopaedic Braces and Supports Market
Health Economics and Outcomes Research (HEOR) Market
Picture Archiving and Communication System (PACS) Market
Contract Development and Manufacturing Organization (CDMO) Market
Latin America Advanced Wound Care Market
Global Implantable Medical Devices Market
Latin America In-vitro Diagnostics Market
Polymyalgia Rheumatica Treatment Market Size
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!
In 2023, the market attained a value of nearly USD 203.73 million.
The market is projected to grow at a CAGR of 4.7% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach around USD 308.68 million by 2032.
The increasing demand for 3D CAD software in major industry verticals, the surging demand for enhanced design and virtual testing technology, and the growing investments in R&D activities are the major drivers of the market.
The key trends propelling the market include rising digitalisation and rapid technological advancements.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major diagnostic methods of polymyalgia rheumatica treatment in the market are blood tests and imaging tests.
The significant drug classes considered in the market report are corticosteroids, disease-modifying anti-rheumatic drugs, and non-steroidal anti-inflammatory drugs, among others.
Oral and parenteral are the different routes of administration for polymyalgia rheumatica treatment.
The various end uses of polymyalgia rheumatica treatment are hospitals, homecare, and speciality clinics, among others.
The major players in the market are Sanofi SA, Apotex Corporation, GlaxoSmithKline plc, AbbVie Inc., and Horizon Therapeutics plc, among others.
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Pricing Plans
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
